CD2 downregulation not only directly impairs CTL activation and cytotoxicity but may also indirectly relieve the suppression of CAD expression in tumor cells by reducing IFN‐γ secretion, thereby promoting pyrimidine synthesis. Here, CAD is linked to neoplasm.